Aimmune's Peanut Immunotherapy Palforzia Gets CHMP Backing
Company Bought By Nestlé Health Science Days Earlier
Palforzia will almost certainly be the first treatment to get the green light for peanut allergy in Europe and its new owner will be hoping for a more successful launch than has been seen in the US.
